Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
Types of Toxins01:36

Types of Toxins

3.1K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.1K
Teratogenicity01:07

Teratogenicity

3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
Relationship with Parents: Attachment01:28

Relationship with Parents: Attachment

214
Parent-child interactions lay the foundation for how we understand relationships throughout life. These interactions are not uniform across families; instead, they are shaped by a range of environmental, emotional, and behavioral factors unique to each caregiver-child dynamic. Social psychologists study these early relationships to understand how patterns formed in infancy influence social functioning and interpersonal behavior in adulthood.Attachment Theory and Early Relational ModelsJohn...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal asthma activity and offspring asthma: a linked-data population study in Australia and Sweden.

BMJ open respiratory research·2026
Same author

Intergenerational Child Protection Contact and Child Development Outcomes: A Whole Population Linked Data Study.

The Medical journal of Australia·2026
Same author

Alopecia Areata Prevalence in Australia: Insights From a Nationally Representative Cross-Sectional Survey Study.

The Australasian journal of dermatology·2026
Same author

Hyper-Cross-Linked Microporous Polymers as Cheap and Efficient Catalysts for the Synthesis of Biodiesel.

ACS applied engineering materials·2026
Same author

Prevalence of Lipoprotein(a) Testing in Patients With Atherosclerotic Cardiovascular Disease Within a Large Australian Cardiology Network.

Heart, lung & circulation·2026
Same author

Treatments for opioid use disorder during pregnancy.

BMJ (Clinical research ed.)·2026

Related Experiment Video

Updated: Jan 10, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K

Prenatal Substance Exposure and Child Protection System Involvement to Age 12 Years.

Madeleine Powell1,2, Rhiannon Pilkington3, Alys Havard1,2

  • 1National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.

Pediatrics
|November 23, 2025
PubMed
Summary
This summary is machine-generated.

Children exposed to substances before birth face high rates of child protection system involvement, with 75% experiencing a report by age 1 and 39% in out-of-home care by age 12. Early intervention in antenatal care can prevent escalation.

More Related Videos

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

10.1K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

579

Related Experiment Videos

Last Updated: Jan 10, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K
Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

10.1K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

579

Area of Science:

  • Public Health
  • Child Welfare
  • Perinatal Health

Background:

  • Prenatal substance exposure significantly increases a child's risk of involvement with child protection services.
  • Understanding the long-term trajectory of this involvement is crucial for effective intervention.

Purpose of the Study:

  • To quantify the risk and timing of child protection system involvement up to age 12 for children with and without prenatal substance exposure.
  • To identify patterns of child protection responses and maltreatment types.

Main Methods:

  • Utilized a whole-population birth cohort from New South Wales, Australia (2007-2018).
  • Included children with documented prenatal substance exposure from various health and child protection records.
  • Assessed risks for screened-in reports, investigations, substantiations, and out-of-home care (OOHC).

Main Results:

  • By age 1, 75% of exposed children had a screened-in report, 34% a substantiation, and 20% OOHC placement.
  • By age 12, 90% had a screened-in report, 61% a substantiation, and 39% OOHC placement.
  • Neglect was recorded in half of exposed children by age 12; health and socioeconomic disadvantages were more prevalent.

Conclusions:

  • Children with prenatal substance exposure experience substantial and early child protection system involvement.
  • Antenatal care and non-stigmatizing support for substance use in pregnancy can prevent escalating child protection interventions.